Qutenza Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
2
Qutenza General Information
Description
Portfolio of a pharmaceutical drugs and its global commercial rights based in Morristown, New Jersey. The asset portfolio consists of Qutenza (capsaicin) 8% patch, a dermal delivery system containing prescription strength capsaicin, which is used for management of neuropathic pain associated with postherpetic neuralgia.
Contact Information
Website
www.qutenza.comCorporate Office
- 360 Mount Kemble Avenue
- 3rd Floor, Suite 3
- Morristown, NJ 07960
- United States
Corporate Office
- 360 Mount Kemble Avenue
- 3rd Floor, Suite 3
- Morristown, NJ 07960
- United States
Qutenza Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Qutenza Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Qutenza FAQs
-
Where is Qutenza headquartered?
Qutenza is headquartered in Morristown, NJ.
-
What industry is Qutenza in?
Qutenza’s primary industry is Buildings and Property.
-
Is Qutenza a private or public company?
Qutenza is a Private company.
-
What is Qutenza’s current revenue?
The current revenue for Qutenza is
. -
Who are Qutenza’s investors?
Acorda Therapeutics and NeurogesX have invested in Qutenza.
-
When was Qutenza acquired?
Qutenza was acquired on 05-Nov-2018.
-
Who acquired Qutenza?
Qutenza was acquired by Grünenthal.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »